In research, poor scalp contact costs a data point. In a clinical department it costs a patient a result, or an afternoon of re-preparation. The clinical edition is the same patent-pending contact mechanism as our research electrode, built in medical-grade materials as a single-use device for routine EEG.
Standard electrodes struggle to reach the scalp through afro-textured, coily and curly hair. Patients are asked to change their hair, sent away, or recorded with contact that isn't good enough to read.
Place, twist, gel, on every patient. No separate protocol for different hair types, and less gel to bridge a gap the electrode has already closed.
The same recording quality regardless of hair type, at the point of care.
Supplied as a single-patient, single-use device. No decontamination cycle, no reuse tracking, no cross-contamination pathway between patients.
No separate protocol, no asking a patient to change their hair, no second appointment because the first recording could not be read.
Early-adopter labs are recording across hair types on their own equipment. That evidence feeds the clinical file.
The same design in medical-grade materials, going through Class I CE marking for the EU and UKCA for the UK, with an FDA Class II pathway to follow. Each declaration of conformity is published on our regulatory page as it is granted.
Once certified, the clinical edition ships to registered departments first. Our long-term goal is NHS partnerships that bring equitable EEG into publicly funded care.
To evaluate the contact mechanism before certification, the research edition is available to research groups now, for research use only. It must not be used for clinical diagnosis or treatment.
Not a commitment to purchase. It tells us who is waiting, roughly how many electrodes and on what systems, so we can plan supply.